Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02077634
What this trial is testing

Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)

Who this might be right for
Prostate Cancer
Universität des Saarlandes 68
Not applicableUnknownNCT06154499
What this trial is testing

Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 1,784
Not applicableLooking for participantsNCT06659614
What this trial is testing

Prostate Tissue BioBank

Who this might be right for
Prostate CancerGenetic Predisposition
Abramson Cancer Center at Penn Medicine 200
Large-scale testing (Phase 3)Study completedNCT00769548
What this trial is testing

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,322
Large-scale testing (Phase 3)Study completedNCT01695135
What this trial is testing

Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 214
Testing effectiveness (Phase 2)Looking for participantsNCT06922318
What this trial is testing

The COSMYC Trial (COmbined Suppression of MYC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Early research (Phase 1)Study completedNCT00916123
What this trial is testing

Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 15
Early research (Phase 1)Study completedNCT00338026
What this trial is testing

A Phase I Study of ECO-4601 in Patients With Advanced Cancer

Who this might be right for
TumorsGliomaColorectal Cancer+5 more
Thallion Pharmaceuticals 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT05779943
What this trial is testing

Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate Carcinoma
Emory University 20
Testing effectiveness (Phase 2)Study completedNCT00430235
What this trial is testing

BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
British Columbia Cancer Agency 39
Testing effectiveness (Phase 2)UnknownNCT02816840
What this trial is testing

PET-CT/MRI in the Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Xuzhou Medical University 90
Not applicableStudy completedNCT00242060
What this trial is testing

Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy

Who this might be right for
Elevated PSAProstate Cancer
University Health Network, Toronto
Not applicableUnknownNCT05024162
What this trial is testing

Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour

Who this might be right for
Prostate Cancer
Nova Scotia Health Authority 60
Testing effectiveness (Phase 2)Study completedNCT00040586
What this trial is testing

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Who this might be right for
Prostatic Neoplasms
BZL Biologics
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282197
What this trial is testing

Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019

Who this might be right for
Prostate Cancer
Peking University First Hospital 40
Not applicableApproved For MarketingNCT01217697
What this trial is testing

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate NeoplasmsGenital Neoplasms, MaleUrogenital Neoplasms+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Testing effectiveness (Phase 2)WithdrawnNCT05046782
What this trial is testing

Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07635524
What this trial is testing

Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 34
Not applicableStudy completedNCT02004223
What this trial is testing

Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Royal North Shore Hospital 42
Very early researchLooking for participantsNCT07164027
What this trial is testing

Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial

Who this might be right for
Prostate Carcinoma
Jonsson Comprehensive Cancer Center 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation